Search in:

Renal Failure Volume 31, 2009 - Issue 10

Submit an article Journal homepage

Free access

2,356

Views

CrossRef citations to date

Altmetric

Clinical Studies

Effect of Spironolactone on Urinary Protein Excretion in Patients with Chronic Kidney Disease

Erkan Sengul Department of Nephrology, Faculty of Medicine, University of Kocaeli, Kocaeli, TurkeyCorrespondence[email protected]

Tayfun Sahin Department of Cardiology, Faculty of Medicine, University of Kocaeli, Kocaeli, Turkey

Erce Sevin Department of Public Health, Faculty of Medicine, University of Kocaeli, Kocaeli, Turkey

Ahmet Yilmaz Department of Nephrology, Faculty of Medicine, University of Kocaeli, Kocaeli, Turkey

Pages 928-932 | Received 12 Jun 2009, Accepted 27 Jul 2009, Published online: 23 Dec 2009

Cite this article
https://doi.org/10.3109/08860220903216121

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions
View PDF PDF

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (8)

Michael Crompton, Laura J. Skinner, Simon C. Satchell & Matthew J. Butler. (2023) Aldosterone: Essential for Life but Damaging to the Vascular Endothelium. Biomolecules 13:6, pages 1004.
Crossref

Hiromi Rakugi, Satoru Yamakawa & Kotaro Sugimoto. (2020) Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: findings from esaxerenone. Hypertension Research 44:4, pages 371-385.
Crossref

Mara Medeiros, Luis Velásquez-Jones, Ana M. Hernández, Guillermo Ramón-García, Saúl Valverde, Yolanda Fuentes, Arindal Vargas, Mauricio Patiño, Rosalba Pérez-Villalva, Juan Antonio Ortega-Trejo, Jonatan Barrera-Chimal & Norma A. Bobadilla. (2017) Randomized Controlled Trial of Mineralocorticoid Receptor Blockade in Children with Chronic Kidney Allograft Nephropathy. Clinical Journal of the American Society of Nephrology 12:8, pages 1291-1300.
Crossref

Michael R. Bristow, Kavita Sharma, Susan F. Assmann, Stuart Linas, Bernard J. Gersh, Christine Grady, Madeline Murguia Rice, Steven Singh, Robin Boineau, Sonja M. McKinlay & Barry H. Greenberg. (2017) Data and Safety Monitoring Board evaluation and management of a renal adverse event signal in TOPCAT. European Journal of Heart Failure 19:4, pages 457-465.
Crossref

Matthew R. Weir, George L. Bakris, Coleman Gross, Martha R. Mayo, Dahlia Garza, Yuri Stasiv, Jinwei Yuan, Lance Berman & Gordon H. Williams. (2016) Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors. Kidney International 90:3, pages 696-704.
Crossref

Jamie S. Hirsch, Yelena Drexler & Andrew S. Bomback. (2014) Aldosterone Blockade in Chronic Kidney Disease. Seminars in Nephrology 34:3, pages 307-322.
Crossref

Sandra Villanueva, Felipe Contreras, Andrés Tapia, Juan E. Carreño, Cesar Vergara, Ernesto Ewertz, Carlos Cespedes, Carlos Irarrazabal, Mauricio Sandoval, Victoria Velarde & Carlos P. Vio. (2014) Basic fibroblast growth factor reduces functional and structural damage in chronic kidney disease. American Journal of Physiology-Renal Physiology 306:4, pages F430-F441.
Crossref

Sara S. Roscioni, Dick de Zeeuw, Stephan J. L. Bakker & Hiddo J. Lambers Heerspink. (2012) Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy. Nature Reviews Nephrology 8:12, pages 691-699.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Effect of Spironolactone on Urinary Protein Excretion in Patients with Chronic Kidney Disease

Articles from other publishers (8)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Effect of Spironolactone on Urinary Protein Excretion in Patients with Chronic Kidney Disease

Citations (8)

Articles from other publishers (8)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date